ESR1 and breast carcinoma: CD146 expression is found to distinguish at least two CAF subpopulations in ER+ breast cancer, among which CD146+ CAFs could promote tamoxifen sensitivity by continuously expressing ER, whereas CD146− CAFs opposite [51].